MedPath
FDA Product

Humalog

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Humalog

0002-7510

Regulatory Information

0002-7510

BLA020563

C73585

August 2, 2023

USA

These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996

HUMAN PRESCRIPTION DRUG LABEL

81

Company Information

006421325

Active Ingredients

Insulin lispro

Quantity: 100 [iU] in 1 mL

Code: GFX7QIS1II

Class Code: ACTIB

Glycerin

Quantity: 16 mg in 1 mL

Code: PDC6A3C0OX

Class Code: IACT

Zinc

Quantity: .0197 mg in 1 mL

Code: J41CSQ7QDS

Class Code: IACT

Metacresol

Quantity: 3.15 mg in 1 mL

Code: GGO4Y809LO

Class Code: IACT

Hydrochloric acid

Code: QTT17582CB

Class Code: IACT

Phenol

Code: 339NCG44TV

Class Code: IACT

Water

Code: 059QF0KO0R

Class Code: IACT

Sodium hydroxide

Code: 55X04QC32I

Class Code: IACT

Sodium Phosphate, Dibasic, Unspecified Form

Quantity: 1.0 mg in 1 mL

Code: GR686LBA74

Class Code: IACT

Active Moieties

Insulin lispro

Code: GFX7QIS1II

© Copyright 2025. All Rights Reserved by MedPath